abstract |
The present invention provides methods for the preparation of TLR-4 receptor agonist E6020 of formula (I) and stereoisomers thereof which, when co-administered with antigens such as vaccines for bacterial and viral diseases, Used as an immune adjuvant. Synthetic intermediates are also provided. |